BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 7520084)

  • 1. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes.
    Arevalo JH; Hassig CA; Stura EA; Sims MJ; Taussig MJ; Wilson IA
    J Mol Biol; 1994 Sep; 241(5):663-90. PubMed ID: 8071992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RNA. Crystal structures of native Fab and three Fab-mononucleotide complexes.
    Pokkuluri PR; Bouthillier F; Li Y; Kuderova A; Lee J; Cygler M
    J Mol Biol; 1994 Oct; 243(2):283-97. PubMed ID: 7523684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition.
    Scheerer P; Kramer A; Otte L; Seifert M; Wessner H; Scholz C; Krauss N; Schneider-Mergener J; Höhne W
    J Mol Recognit; 2007; 20(4):263-74. PubMed ID: 17712773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes.
    Friedman AR; Roberts VA; Tainer JA
    Proteins; 1994 Sep; 20(1):15-24. PubMed ID: 7529922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
    Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
    Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
    Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
    Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
    Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.
    Evans SV; Rose DR; To R; Young NM; Bundle DR
    J Mol Biol; 1994 Sep; 241(5):691-705. PubMed ID: 8071993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
    Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA
    Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rigid-body docking with mutant constraints of influenza hemagglutinin with antibody HC19.
    Cherfils J; Bizebard T; Knossow M; Janin J
    Proteins; 1994 Jan; 18(1):8-18. PubMed ID: 7511810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of an antigen-binding fragment bound to single-stranded DNA.
    Tanner JJ; Komissarov AA; Deutscher SL
    J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.